
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer
Yu Wang, Yingying Wang, Zhiyuan Qin, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 3, pp. 291-306
Closed Access | Times Cited: 110
Yu Wang, Yingying Wang, Zhiyuan Qin, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 3, pp. 291-306
Closed Access | Times Cited: 110
Showing 1-25 of 110 citing articles:
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 132
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 132
Extracellular Vesicles: New Classification and Tumor Immunosuppression
Mona Sheta, Eman A. Taha, Yanyin Lu, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 113
Mona Sheta, Eman A. Taha, Yanyin Lu, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 113
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 113
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 113
ATP-binding cassette efflux transporters and MDR in cancer
Manasi S. Pote, Rajesh N. Gacche
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103537-103537
Open Access | Times Cited: 97
Manasi S. Pote, Rajesh N. Gacche
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103537-103537
Open Access | Times Cited: 97
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 75
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 75
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 73
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 73
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 27-27
Open Access | Times Cited: 55
Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 27-27
Open Access | Times Cited: 55
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
Jiaqi Tian, Zhengpu Han, Dandan Song, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7923-7940
Open Access | Times Cited: 54
Jiaqi Tian, Zhengpu Han, Dandan Song, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7923-7940
Open Access | Times Cited: 54
Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 48
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20
Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
Zhimin Xu, Yingxin Zhang, Huanyan Dai, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4750-4750
Open Access | Times Cited: 42
Zhimin Xu, Yingxin Zhang, Huanyan Dai, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4750-4750
Open Access | Times Cited: 42
Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment
Shulong Shi, Sihao Zhao, Xinchen Tian, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106777-106777
Open Access | Times Cited: 24
Shulong Shi, Sihao Zhao, Xinchen Tian, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106777-106777
Open Access | Times Cited: 24
Exosomal ncRNAs in liquid biopsies for lung cancer
Md Sadique Hussain, Gaurav Gupta, Nehmat Ghaboura, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 119983-119983
Closed Access | Times Cited: 15
Md Sadique Hussain, Gaurav Gupta, Nehmat Ghaboura, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 119983-119983
Closed Access | Times Cited: 15
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 14
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 14
Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look
Zahra Abbasi‐Malati, Seyed Ghader Azizi, Soheil Zamen Milani, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Zahra Abbasi‐Malati, Seyed Ghader Azizi, Soheil Zamen Milani, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Autophagy orchestrates resistance in hepatocellular carcinoma cells
Homeyra Seydi, Kosar Nouri, Niloufar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114487-114487
Open Access | Times Cited: 21
Homeyra Seydi, Kosar Nouri, Niloufar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114487-114487
Open Access | Times Cited: 21
Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
Xiang Lin, Xinyu Yang, Yu‐Shang Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Xiang Lin, Xinyu Yang, Yu‐Shang Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
Resistance of Lenvatinib in Hepatocellular Carcinoma
Qiuran Xu, Dong‐Sheng Huang, Jinhui Guo, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 11, pp. 865-878
Closed Access | Times Cited: 26
Qiuran Xu, Dong‐Sheng Huang, Jinhui Guo, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 11, pp. 865-878
Closed Access | Times Cited: 26
Drug Resistance in Cancers: A Free Pass for Bullying
Jing Li, Xiao Li, Qie Guo
Cells (2022) Vol. 11, Iss. 21, pp. 3383-3383
Open Access | Times Cited: 23
Jing Li, Xiao Li, Qie Guo
Cells (2022) Vol. 11, Iss. 21, pp. 3383-3383
Open Access | Times Cited: 23
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
Po-Shuan Huang, Ling‐Yu Wang, Yiwen Wang, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 869-869
Open Access | Times Cited: 15
Po-Shuan Huang, Ling‐Yu Wang, Yiwen Wang, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 869-869
Open Access | Times Cited: 15
Long non-coding RNAs and gastric cancer: An update of potential biomarkers and therapeutic applications
Sayedeh Azimeh Hosseini, Mohammad Hossein Haddadi, Hadis Fathizadeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114407-114407
Open Access | Times Cited: 15
Sayedeh Azimeh Hosseini, Mohammad Hossein Haddadi, Hadis Fathizadeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114407-114407
Open Access | Times Cited: 15
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Variability in the volatile constituents and biological activities of Achillea millefolium L. essential oils obtained from different plant parts and by different solvents
Hamdoon A. Mohammed, Muhamad Abd‐Elraouf, Ghassan M. Sulaiman, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 105103-105103
Open Access | Times Cited: 14
Hamdoon A. Mohammed, Muhamad Abd‐Elraouf, Ghassan M. Sulaiman, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 105103-105103
Open Access | Times Cited: 14
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Simin Ye, Shiyu Chen, Xiaoyan Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Simin Ye, Shiyu Chen, Xiaoyan Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5